Tramadol - Addpharma
Alternative Names: AD 2112Latest Information Update: 28 Jun 2023
At a glance
- Originator Addpharma
- Class Anisoles; Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for phase-I development in Pain(In volunteers) in South Korea (Parenteral)
- 16 Jul 2020 Addpharma completes the phase I trial in Pain (In volunteers) in South Korea (PO) (NCT04375865)
- 30 May 2020 Phase-I clinical trials in Pain (In volunteers) in South Korea (Parenteral) (NCT04375865)